Evidence map›Paper›PMID 26475854›Full record

ArticleThe Journal of biological chemistry2015

Insights into Ubiquitination from the Unique Clamp-like Binding of the RING E3 AO7 to the E2 UbcH5B.

Shengjian Li, Yu-He Liang, Jennifer Mariano, Meredith B Metzger, Daniel K Stringer, Ventzislava A Hristova, Jess Li, Paul A Randazzo, Yien Che Tsai, Xinhua Ji and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Structural Diversity of Ubiquitin E3 Ligase.Molecules (Basel, Switzerland) · 2021
    Review
  15. NEDD8 and ubiquitin ligation by cullin-RING E3 ligases.Current opinion in structural biology · 2021
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Shengjian LiFrom the Laboratory of Protein Dynamics and Signaling.
Yu-He LiangMacromolecular Crystallography Laboratory, and.
Jennifer MarianoFrom the Laboratory of Protein Dynamics and Signaling.
Meredith B MetzgerFrom the Laboratory of Protein Dynamics and Signaling.
Daniel K StringerFrom the Laboratory of Protein Dynamics and Signaling.
Ventzislava A HristovaFrom the Laboratory of Protein Dynamics and Signaling.
Jess LiStructural Biophysics Laboratory, Center for Cancer Research, NCI, National Institutes of Health, Frederick, Maryland 21702 and.
Paul A Randazzothe Laboratory of Cell and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892.
Yien Che TsaiFrom the Laboratory of Protein Dynamics and Signaling.
Xinhua JiMacromolecular Crystallography Laboratory, and jix@mail.nih.gov.
Allan M WeissmanFrom the Laboratory of Protein Dynamics and Signaling, weissmaa@mail.nih.gov.
National Institutes of Health · US

Funding

Biomolecular Structure and Mechanism, Structure-Based Drug DesignZIABC010326 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JI, XINHUA · 2009 to 2024
$27.3M
Intramural NIH HHS
6 · The paper itself

Abstract

RING proteins constitute the largest class of E3 ubiquitin ligases. Unlike most RINGs, AO7 (RNF25) binds the E2 ubiquitin-conjugating enzyme, UbcH5B (UBE2D2), with strikingly high affinity. We have defined, by co-crystallization, the distinctive means by which AO7 binds UbcH5B. AO7 contains a structurally unique UbcH5B binding region (U5BR) that is connected by an 11-amino acid linker to its RING domain, forming a clamp surrounding the E2. The U5BR interacts extensively with a region of UbcH5B that is distinct from both the active site and the RING-interacting region, referred to as the backside of the E2. An apparent paradox is that the high-affinity binding of the AO7 clamp to UbcH5B, which is dependent on the U5BR, decreases the rate of ubiquitination. We establish that this is a consequence of blocking the stimulatory, non-covalent, binding of ubiquitin to the backside of UbcH5B. Interestingly, when non-covalent backside ubiquitin binding cannot occur, the AO7 clamp now enhances the rate of ubiquitination. The high-affinity binding of the AO7 clamp to UbcH5B has also allowed for the co-crystallization of previously described and functionally important RING mutants at the RING-E2 interface. We show that mutations having marked effects on function only minimally affect the intermolecular interactions between the AO7 RING and UbcH5B, establishing a high degree of complexity in activation through the RING-E2 interface.

Indexed as

UbiquitinationHumansMutationProtein BindingProtein Structure, TertiaryUbiquitin-Conjugating EnzymesUbiquitin-Protein LigasesRNF25 protein, humanUBE2D2 protein, humanUbiquitin-Conjugating EnzymesUbiquitin-Protein Ligasesallosteric regulationcrystallographyE3 ubiquitin ligaseproteolysisRING fingerubiquitinubiquitin-conjugating enzyme (E2 enzyme)

Identifiers

PMID26475854
PMCPMC4683248
OpenAlexW2258175065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.